{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:50:53Z","timestamp":1783335053754,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB216004"],"award-info":[{"award-number":["20232BAB216004"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03362-0","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T08:02:16Z","timestamp":1724054536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The newly proposed plasma-glycosylated hemoglobin A1c\/High-Density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population"],"prefix":"10.1186","volume":"24","author":[{"given":"Shiming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maobin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotai","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"3362_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0035-1562943","volume":"35","author":"SK Satapathy","year":"2015","unstructured":"Satapathy SK, Sanyal AJ. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin Liver Dis. 2015;35:221\u201335.","journal-title":"Semin Liver Dis"},{"key":"3362_CR2","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/nu15102323","volume":"15","author":"N Bhat","year":"2023","unstructured":"Bhat N, Mani A. Dysregulation of lipid and glucose metabolism in nonalcoholic fatty liver disease. Nutrients. 2023;15:2323.","journal-title":"Nutrients"},{"key":"3362_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3362_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00535-020-01684-w","volume":"55","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Dong L, Holmen J, Gilroy R, Krong J, Charlton M. Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system. J Gastroenterol. 2020;55:722\u201330.","journal-title":"J Gastroenterol"},{"key":"3362_CR5","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","volume":"78","author":"P Hartmann","year":"2023","unstructured":"Hartmann P, Zhang X, Loomba R, Schnabl B. Global and national prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019. Hepatology. 2023;78:1168\u201381.","journal-title":"Hepatology"},{"key":"3362_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","volume":"79","author":"MH Le","year":"2023","unstructured":"Le MH, Le DM, Baez TC, Wu Y, Ito T, Lee EY, et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023;79:287\u201395.","journal-title":"J Hepatol"},{"key":"3362_CR7","doi-asserted-by":"publisher","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","volume":"7","author":"JM Paik","year":"2023","unstructured":"Paik JM, Henry L, Younossi Y, Ong J, Alqahtani S, Younossi ZM. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun. 2023;7:e0251.","journal-title":"Hepatol Commun"},{"key":"3362_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589\u2013600.","journal-title":"J Hepatol"},{"key":"3362_CR9","doi-asserted-by":"publisher","first-page":"155220","DOI":"10.1016\/j.metabol.2022.155220","volume":"133","author":"H Peng","year":"2022","unstructured":"Peng H, Wang S, Wang M, Ye Y, Xue E, Chen X, et al. Nonalcoholic fatty liver disease and cardiovascular diseases: a mendelian randomization study. Metabolism. 2022;133:155220.","journal-title":"Metabolism"},{"key":"3362_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","volume":"79","author":"AM Allen","year":"2023","unstructured":"Allen AM, Lazarus JV, Younossi ZM. Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties. J Hepatol. 2023;79:209\u201317.","journal-title":"J Hepatol"},{"key":"3362_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79:842\u201352.","journal-title":"J Hepatol"},{"key":"3362_CR12","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.cgh.2023.01.006","volume":"21","author":"L de Avila","year":"2023","unstructured":"de Avila L, Henry L, Paik JM, Ijaz N, Weinstein AA, Younossi ZM. Nonalcoholic fatty liver disease is independently Associated with higher all-cause and cause-specific mortality. Clin Gastroenterol Hepatol. 2023;21:2588\u2013e25963.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3362_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","volume":"68","author":"T Jensen","year":"2018","unstructured":"Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68:1063\u201375.","journal-title":"J Hepatol"},{"key":"3362_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10408363.2017.1299684","volume":"54","author":"S Yazdanpanah","year":"2017","unstructured":"Yazdanpanah S, Rabiee M, Tahriri M, Abdolrahim M, Rajab A, Jazayeri HE, et al. Evaluation of glycated albumin (GA) and GA\/HbA1c ratio for diagnosis of diabetes and glycemic control: a comprehensive review. Crit Rev Clin Lab Sci. 2017;54:219\u201332.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3362_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccc.2018.11.010","volume":"35","author":"A Balintescu","year":"2019","unstructured":"Balintescu A, M\u00e5rtensson J. Hemoglobin A1c and permissive hyperglycemia in patients in the Intensive Care Unit with Diabetes. Crit Care Clin. 2019;35:289\u2013300.","journal-title":"Crit Care Clin"},{"key":"3362_CR16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","volume":"158","author":"V Azzu","year":"2020","unstructured":"Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Adipose tissue-liver Cross Talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology. 2020;158:1899\u2013912.","journal-title":"Gastroenterology"},{"key":"3362_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65:1109\u201323.","journal-title":"Metabolism"},{"key":"3362_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","volume":"65","author":"M Mota","year":"2016","unstructured":"Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65:1049\u201361.","journal-title":"Metabolism"},{"key":"3362_CR19","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1093\/eurheartj\/ehx274","volume":"38","author":"PJ Barter","year":"2017","unstructured":"Barter PJ, Rye KA. HDL cholesterol concentration or HDL function: which matters? Eur Heart J. 2017;38:2487\u20139.","journal-title":"Eur Heart J"},{"key":"3362_CR20","doi-asserted-by":"publisher","first-page":"8985","DOI":"10.3390\/ijms21238985","volume":"21","author":"JT Stadler","year":"2020","unstructured":"Stadler JT, Marsche G. Obesity-related changes in high-density lipoprotein metabolism and function. Int J Mol Sci. 2020;21:8985.","journal-title":"Int J Mol Sci"},{"key":"3362_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12944-019-1170-9","volume":"18","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chen J, Tang X, Luo Q, Xu D, Yu B. Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids Health Dis. 2019;18:223.","journal-title":"Lipids Health Dis"},{"key":"3362_CR22","doi-asserted-by":"publisher","first-page":"9238566","DOI":"10.1155\/2021\/9238566","volume":"2021","author":"X Hu","year":"2021","unstructured":"Hu X, Li W, Wang C, Zhang H, Lu H, Li G, et al. Association between the Plasma-Glycosylated Hemoglobin A1c\/High-Density Lipoprotein Cholesterol Ratio and carotid atherosclerosis: a retrospective study. J Diabetes Res. 2021;2021:9238566.","journal-title":"J Diabetes Res"},{"key":"3362_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43:139\u201348.","journal-title":"Int J Obes (Lond)"},{"key":"3362_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3350\/cmh.2020.0163","volume":"26","author":"JH Choi","year":"2020","unstructured":"Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26:662\u20139.","journal-title":"Clin Mol Hepatol"},{"key":"3362_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"3362_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"3362_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558\u201369.","journal-title":"Korean J Anesthesiol"},{"key":"3362_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"key":"3362_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"3362_CR30","doi-asserted-by":"publisher","first-page":"101167","DOI":"10.1016\/j.molmet.2021.101167","volume":"50","author":"V Ajmera","year":"2021","unstructured":"Ajmera V, Loomba R. Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab. 2021;50:101167.","journal-title":"Mol Metab"},{"key":"3362_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"3362_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","volume":"8","author":"MA Tincopa","year":"2023","unstructured":"Tincopa MA, Loomba R. Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lancet Gastroenterol Hepatol. 2023;8:660\u201370.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3362_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/bmj.38947.627847.AE","volume":"333","author":"TM Reynolds","year":"2006","unstructured":"Reynolds TM, Smellie WS, Twomey PJ. Glycated haemoglobin (HbA1c) monitoring. BMJ. 2006;333:586\u20138.","journal-title":"BMJ"},{"key":"3362_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3343\/alm.2013.33.6.393","volume":"33","author":"C Weykamp","year":"2013","unstructured":"Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med. 2013;33:393\u2013400.","journal-title":"Ann Lab Med"},{"key":"3362_CR35","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44:S15\u201333.","journal-title":"Diabetes Care"},{"key":"3362_CR36","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.3390\/nu14204434","volume":"14","author":"J Chen","year":"2022","unstructured":"Chen J, Zhou H, Jin H, Liu K. Role of inflammatory factors in mediating the effect of lipids on nonalcoholic fatty liver disease: a Two-Step, multivariable mendelian randomization study. Nutrients. 2022;14:4434.","journal-title":"Nutrients"},{"key":"3362_CR37","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1053\/gast.2001.29590","volume":"121","author":"B Malassagne","year":"2001","unstructured":"Malassagne B, Ferret PJ, Hammoud R, Tulliez M, Bedda S, Tr\u00e9b\u00e9den H, et al. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology. 2001;121:1451\u20139.","journal-title":"Gastroenterology"},{"key":"3362_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1586\/egh.11.6","volume":"5","author":"N Alkhouri","year":"2011","unstructured":"Alkhouri N, Carter-Kent C, Feldstein AE. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev Gastroenterol Hepatol. 2011;5:201\u201312.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3362_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cld.2009.07.003","volume":"13","author":"WK Syn","year":"2009","unstructured":"Syn WK, Choi SS, Diehl AM. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis. 2009;13:565\u201380.","journal-title":"Clin Liver Dis"},{"key":"3362_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2001-12927","volume":"21","author":"S Chitturi","year":"2001","unstructured":"Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27\u201341.","journal-title":"Semin Liver Dis"},{"key":"3362_CR41","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","volume":"42","author":"D Pessayre","year":"2005","unstructured":"Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol. 2005;42:928\u201340.","journal-title":"J Hepatol"},{"key":"3362_CR42","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.26226","volume":"58","author":"K Begriche","year":"2013","unstructured":"Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology. 2013;58:1497\u2013507.","journal-title":"Hepatology"},{"key":"3362_CR43","doi-asserted-by":"publisher","first-page":"1078652","DOI":"10.3389\/fendo.2022.1078652","volume":"13","author":"J Hou","year":"2022","unstructured":"Hou J, Liu Y, Deng Z, Sun J, Zhao M, Glycohemoglobin. A new warning strategy for non-alcoholic fatty liver disease: study from the NHANES 2017\u20132020. Front Endocrinol (Lausanne). 2022;13:1078652.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3362_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40842-020-00097-1","volume":"6","author":"S Tomah","year":"2020","unstructured":"Tomah S, Alkhouri N, Hamdy O. Nonalcoholic fatty liver disease and type 2 diabetes: where do diabetologists stand? Clin Diabetes Endocrinol. 2020;6:9.","journal-title":"Clin Diabetes Endocrinol"},{"key":"3362_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbalip.2016.04.013","volume":"1861","author":"M Trieb","year":"2016","unstructured":"Trieb M, Horvath A, Birner-Gruenberger R, Spindelboeck W, Stadlbauer V, Taschler U, et al. Liver disease alters high-density lipoprotein composition, metabolism and function. Biochim Biophys Acta. 2016;1861:630\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"3362_CR46","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","volume":"33","author":"L Camont","year":"2013","unstructured":"Camont L, Lhomme M, Rached F, Le Goff W, N\u00e8gre-Salvayre A, Salvayre R, et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler Thromb Vasc Biol. 2013;33:2715\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3362_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/clinchem\/28.3.525","volume":"28","author":"J Rubi\u00e9s-Prat","year":"1982","unstructured":"Rubi\u00e9s-Prat J, Masdeu S, Nubiola AR, Chac\u00f3n P, Holguera C, Masana L. High-density lipoprotein cholesterol and phospholipids, and apoprotein A in serum of patients with liver disease. Clin Chem. 1982;28:525\u20137.","journal-title":"Clin Chem"},{"key":"3362_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.23736\/S0026-4806.19.05978-0","volume":"110","author":"A Klisic","year":"2019","unstructured":"Klisic A, Abenavoli L, Fagoonee S, Kavaric N, Kocic G, Nini\u0107 A. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. Minerva Med. 2019;110:191\u20138.","journal-title":"Minerva Med"},{"key":"3362_CR49","first-page":"1795851","volume":"2021","author":"BH Rao","year":"2021","unstructured":"Rao BH, Nair P, Koshy AK, Krishnapriya S, Greeshma CR, Venu RP. Role of high-density lipoprotein cholesterol (HDL-C) as a clinical predictor of decompensation in patients with chronic liver disease (CLD). Int J Hepatol. 2021;2021:1795851.","journal-title":"Int J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03362-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T09:03:32Z","timestamp":1724058212000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3362"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03362-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved secondary analysis of the NAGALA cohort data, and the research protocol was approved by the Ethics Committee of Jiangxi Provincial People\u2019s Hospital. Additionally, due to the de-identification of the current dataset regarding subject identifiers, the Ethics Committee of Jiangxi Provincial People\u2019s Hospital waived the requirement for informed consent from the subjects (IRB2021-066). The entire research process followed the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}